Year

Vaccine Licensure

Legislation and/or Policy Statements

IOM Reports on Vaccine Safety

1996

DTaP vaccine licensed for first three doses given in infancy (Tripedia and ACEL-IMUNE were previously licensed for only the 4th and 5th doses).

ACIP recommends using IPV for the first 2 polio vaccinations, followed by OPV for remaining doses. Intended to be a transitional schedule for 3–5 years until an all-IPV series is available

Options for Poliomyelitis Vaccinations in the United States: Workshop Summary

 

ACIP recommends children 12months–12 years receive Varicella vaccine

 

1997

Additional DTaP vaccine (Infanrix) licensed for first 4 doses of 5-part series

ACIP recommends DTaP in place of DTP

Vaccine Safety Forum: Summary of Two Workshops

 

Risk Communication and Vaccination: Workshop Summary

1998

Additional DTaP vaccine (Certiva) licensed for first 4 doses of 5-part series

ACIP updates MMR recommendation, encouraging use of the combined MMR vaccine

 

1999

 

ACIP updates varicella vaccine recommendation, requiring immunity for child care and school entry

ACIP recommends an all-IPV schedule begin January 2000 to prevent cases of vaccine-associated paralytic polio

AAP and PHS recommend removal of thimerosal from vaccines

Also recommended postponement of hepatitis B vaccine from birth to 2–6 months for infants of hepatitis B surface antigen-negative mothers

Additional supply of thimerosal-free hepatitis B vaccine made available

MMWR notifies readers of the availability of a thimerosal-free hepatitis B vaccine, enabling the resumption of the birth dose

 

2000

Pneumococcal vaccine for infants and young

ACIP recommends pneumococcal vaccination for all chil

 



The National Academies | 500 Fifth St. N.W. | Washington, D.C. 20001
Copyright © National Academy of Sciences. All rights reserved.
Terms of Use and Privacy Statement